32 related articles for article (PubMed ID: 12885362)
1. Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer.
Li Y; Zhao S; Zhang F; Jin G; Zhou Y; Li P; Shin D; Yang X
Int J Hyperthermia; 2020; 37(1):101-109. PubMed ID: 31969028
[No Abstract] [Full Text] [Related]
2. Expression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells.
Ingemarsdotter CK; Poddar S; Mercier S; Patzel V; Lever AML
Mol Ther Nucleic Acids; 2017 Jun; 7():140-154. PubMed ID: 28624190
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements.
Wang WD; Chen ZT; Li R; Li DZ; Duan YZ; Cao ZH
Cancer Sci; 2005 Dec; 96(12):918-24. PubMed ID: 16367913
[TBL] [Abstract][Full Text] [Related]
4. A Herpes Simplex Virus Thymidine Kinase-Induced Mouse Model of Hepatocellular Carcinoma Associated with Up-Regulated Immune-Inflammatory-Related Signals.
Gong Z; Ma Q; Wang X; Cai Q; Gong X; Genchev GZ; Lu H; Zeng F
Genes (Basel); 2018 Jul; 9(8):. PubMed ID: 30060537
[TBL] [Abstract][Full Text] [Related]
5. Major Virion Tegument Protein VP22 Targets Nuclear Matrix and Chromatin upon Entry into Cells during Productive Herpes Simplex Virus 1 Infection.
Chi I; Blaho JA
Microorganisms; 2024 Mar; 12(3):. PubMed ID: 38543571
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor-specific Fab immunogene.
Ohtake Y; Chen J; Gamou S; Takayanagi A; Mashima Y; Oguchi Y; Shimizu N
Jpn J Cancer Res; 1999 Apr; 90(4):460-8. PubMed ID: 10363586
[TBL] [Abstract][Full Text] [Related]
7. A lentivirus-vectored feline erythropoietin gene therapy strategy in tissue culture and rodent models for the potential treatment of chronic renal disease-associated anemia.
Cook SE; Castillo D; Wolf T; Hillman C; Bauer K; Williams S; Murphy BG
Am J Vet Res; 2024 Jun; 85(6):. PubMed ID: 38626794
[TBL] [Abstract][Full Text] [Related]
8. Nanotargeted Cationic Lipid Microbubbles Carrying HSV-TK Gene Inhibit the Development of Subcutaneous Liver Tumor Model After HIFU Ablation.
Liu Y; Zhang Y; Du D; Gu X; Zhang X; Hong G; Lai X
J Ultrasound Med; 2024 Jan; 43(1):95-107. PubMed ID: 37815381
[TBL] [Abstract][Full Text] [Related]
9. Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.
El-Ayoubi A; Arakelyan A; Klawitter M; Merk L; Hakobyan S; Gonzalez-Menendez I; Quintanilla Fend L; Holm PS; Mikulits W; Schwab M; Danielyan L; Naumann U
Mol Oncol; 2024 Mar; 18(3):528-546. PubMed ID: 38115217
[TBL] [Abstract][Full Text] [Related]
10. Editorial Expression of Concern: Herpes simplex virus thymidine kinase/ganciclovir-induced cell death is enhanced by co-expression of caspase-3 in ovarian carcinoma cells.
McNeish IA; Tenev T; Bell S; Marani M; Vassaux G; Lemoine N
Cancer Gene Ther; 2024 May; ():. PubMed ID: 38698243
[No Abstract] [Full Text] [Related]
11. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
[TBL] [Abstract][Full Text] [Related]
12. In situ use of suicide genes for cancer therapy.
Freeman SM; Whartenby KA; Freeman JL; Abboud CN; Marrogi AJ
Semin Oncol; 1996 Feb; 23(1):31-45. PubMed ID: 8607030
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J
J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071
[TBL] [Abstract][Full Text] [Related]
14. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
Kong BH; Wang WX; Liu CS; Ma DX; Qu X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
16. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
